Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04652960
Title Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

Sezary's disease

mycosis fungoides

Therapies

Duvelisib + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital in Arizona Recruiting Phoenix Arizona 85054 United States Details
University of Colorado Hospital Recruiting Aurora Colorado 80045 United States Details
Mayo Clinic in Florida Recruiting Jacksonville Florida 32224-9980 United States Details
Dana-Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
Mayo Clinic in Rochester Recruiting Rochester Minnesota 55905 United States Details
Siteman Cancer Center at West County Hospital Recruiting Creve Coeur Missouri 63141 United States Details
Washington University School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
Siteman Cancer Center-South County Recruiting Saint Louis Missouri 63129 United States Details
Siteman Cancer Center at Christian Hospital Recruiting Saint Louis Missouri 63136 United States Details
Siteman Cancer Center at Saint Peters Hospital Recruiting Saint Peters Missouri 63376 United States Details
NYP/Weill Cornell Medical Center Suspended New York New York 10065 United States Details
University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field